(firstQuint)Dose Escalating Trial of Mistletoe Extract in Patients With Advanced Solid Tumors.

 This study is a Phase I study that consists of two phases: a dose escalation phase and an expansion phase.

 The dose escalation phase will be used to evaluate the safety and toxicity of Helixor(R) M (mistletoe extract).

 An accelerated titration design (ATD) will be utilized to determine the MTD.

 The expansion phase will be used to obtain preliminary efficacy data about Helixor(R) M.

.

 Dose Escalating Trial of Mistletoe Extract in Patients With Advanced Solid Tumors@highlight

This study will seek to determine the safety and toxicity profile as well as the maximum tolerated dose of Helixor(R) M in patients with advanced solid tumors.

